Sanara Med Tech Inc. - Understand $smti stock

$SMTI Market Cap: $314.2 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$78.06M

TTM

Gross Margin

90.14%

TTM

Net Earnings

-$8.363M

TTM

Current Assets

$31.91M

Q3 2024

Current Liabilities

$14.34M

Q3 2024

Current Ratio

222.52%

Q3 2024

Total Assets

$88.55M

Q3 2024

Total Liabilities

$49.09M

Q3 2024

Book Value

$39.45M

Q3 2024

Cash

$16.28M

Q3 2024

P/E

-37.56

Nov 29, 2024 EST

Free Cash Flow

-$1.990M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$64.99M	$45.84M	$24.14M	$15.59M	$11.77M	$5.840M	$6.300M	$5.510M	$3.370M	$2.630M	$1.730M	$1.170M	$2.210M	$910.0K	$290.0K	$290.0K	$630.0K
YoY Change	41.77%	89.87%	54.87%	32.46%	101.54%	-7.3%	14.34%	63.5%	28.14%	52.02%	47.86%	-47.06%	142.86%	213.79%	0.0%	-53.97%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$64.99M	$45.84M	$24.14M	$15.59M	$11.77M	$5.840M	$6.300M	$5.510M	$3.370M	$2.630M	$1.730M	$1.170M	$2.210M	$910.0K	$290.0K	$290.0K	$630.0K
Cost Of Revenue	$7.853M	$6.361M	$2.311M	$1.620M	$1.210M	$510.0K	$810.0K	$940.0K	$890.0K	$800.0K	$790.0K	$800.0K	$800.0K	$540.0K	$620.0K	$420.0K	$220.0K
Gross Profit	$57.14M	$39.48M	$21.83M	$13.97M	$10.56M	$5.330M	$5.500M	$4.560M	$2.480M	$1.830M	$930.0K	$380.0K	$1.410M	$370.0K	-$330.0K	-$130.0K	$410.0K
Gross Profit Margin	87.92%	86.12%	90.43%	89.61%	89.72%	91.27%	87.3%	82.76%	73.59%	69.58%	53.76%	32.48%	63.8%	40.66%	-113.79%	-44.83%	65.08%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Selling, General & Admin	$56.99M	$45.98M	$28.05M	$18.71M	$13.18M	$5.750M	$5.300M	$4.780M	$3.390M	$3.840M	$3.810M	$5.710M	$2.750M	$2.340M	$1.050M	$1.620M	$810.0K
YoY Change	23.97%	63.89%	49.94%	41.96%	129.22%	8.49%	10.88%	41.0%	-11.72%	0.79%	-33.27%	107.64%	17.52%	122.86%	-35.19%	100.0%
% of Gross Profit	99.75%	116.45%	128.49%	133.93%	124.81%	107.88%	96.36%	104.82%	136.69%	209.84%	409.68%	1502.63%	195.04%	632.43%			197.56%
Research & Development	$4.132M	$3.367M	$558.7K
YoY Change	22.73%	502.65%
% of Gross Profit	7.23%	8.53%	2.56%
Depreciation & Amortization	$456.1K	$407.8K	$597.0K	$290.0K	$120.0K	$80.00K	$80.00K	$60.00K	$60.00K	$60.00K	$50.00K	$60.00K	$470.0K	$470.0K	$120.0K	$10.00K	$20.00K
YoY Change	11.86%	-31.69%	105.86%	141.67%	50.0%	0.0%	33.33%	0.0%	0.0%	20.0%	-16.67%	-87.23%	0.0%	291.67%	1100.0%	-50.0%
% of Gross Profit	0.8%	1.03%	2.73%	2.08%	1.14%	1.5%	1.45%	1.32%	2.42%	3.28%	5.38%	15.79%	33.33%	127.03%			4.88%
Operating Expenses	$61.35M	$51.71M	$29.21M	$19.01M	$13.30M	$5.830M	$5.380M	$4.840M	$3.450M	$3.900M	$3.870M	$5.760M	$3.220M	$2.840M	$1.180M	$1.630M	$820.0K
YoY Change	18.64%	77.05%	53.65%	42.93%	128.13%	8.36%	11.16%	40.29%	-11.54%	0.78%	-32.81%	78.88%	13.38%	140.68%	-27.61%	98.78%
Operating Profit	-$4.215M	-$12.23M	-$7.376M	-$5.040M	-$2.740M	-$500.0K	$120.0K	-$280.0K	-$970.0K	-$2.070M	-$2.940M	-$5.380M	-$1.810M	-$2.470M	-$1.510M	-$1.760M	-$410.0K
YoY Change	-65.54%	65.84%	46.35%	83.94%	448.0%	-516.67%	-142.86%	-71.13%	-53.14%	-29.59%	-45.35%	197.24%	-26.72%	63.58%	-14.2%	329.27%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Interest Expense	$475.8K	$284.7K	-$617.6K	-$10.00K	-$110.0K	-$80.00K	-$130.0K	-$170.0K	-$180.0K	-$220.0K	-$1.360M	$4.500M	-$50.00K	-$140.0K	-$460.0K	-$10.00K	-$140.0K
YoY Change	67.09%	-146.1%	6076.4%	-90.91%	37.5%	-38.46%	-23.53%	-5.56%	-18.18%	-83.82%	-130.22%	-9100.0%	-64.29%	-69.57%	4500.0%	-92.86%
% of Operating Profit							-108.33%
Other Income/Expense, Net	-$224.7K	-$1.705M	$0.00	$10.00K	$10.00K	-$20.00K	$0.00	$0.00		$0.00	$200.0K	$0.00		-$2.010M	-$1.040M
YoY Change	-86.82%		-100.0%	0.0%	-150.0%					-100.0%				93.27%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Pretax Income	-$4.440M	-$13.94M	-$7.994M	-$4.450M	-$2.840M	-$600.0K	$330.0K	-$420.0K	-$1.340M	-$2.280M	-$4.150M	-$1.850M	-$12.74M	-$6.640M	-$3.020M	-$1.770M	-$540.0K
YoY Change	-68.14%	74.35%	79.64%	56.69%	373.33%	-281.82%	-178.57%	-68.66%	-41.23%	-45.06%	124.32%	-85.48%	91.87%	119.87%	70.62%	227.78%
Income Tax		-$5.845M							$0.00		$0.00		$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$4.303M	-$7.937M	-$7.922M	-$4.360M	-$2.810M	-$600.0K	$330.0K	-$420.0K	-$1.340M	-$2.280M	-$4.150M	-$1.850M	-$12.74M	-$6.640M	-$3.020M	-$1.770M	-$540.0K
YoY Change	-45.79%	0.2%	81.7%	55.16%	368.33%	-281.82%	-178.57%	-68.66%	-41.23%	-45.06%	124.32%	-85.48%	91.87%	119.87%	70.62%	227.78%
Net Earnings / Revenue	-6.62%	-17.31%	-32.81%	-27.97%	-23.87%	-10.27%	5.24%	-7.62%	-39.76%	-86.69%	-239.88%	-158.12%	-576.47%	-729.67%	-1041.38%	-610.34%	-85.71%
Basic Earnings Per Share	-$0.52	-$1.00	-$1.08
Diluted Earnings Per Share	-$0.52	-$1.00	-$1.079M	-$760.9K	-$1.319M	-$276.5K	$157.9K	-$385.3K	-$1.252M	-$2.591M	-$5.321M	-$2.937M	-$23.16M	-$18.44M	-$10.41M	-$8.045M	-$3.375M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Cash & Short-Term Investments	$5.147M	$8.959M	$18.65M	$460.0K	$6.610M	$730.0K	$460.0K	$830.0K	$180.0K	$520.0K	$40.00K	$50.00K	$0.00	$50.00K	$0.00	$0.00	$0.00
YoY Change	-42.55%	-51.97%	3954.97%	-93.04%	805.48%	58.7%	-44.58%	361.11%	-65.38%	1200.0%	-20.0%		-100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$608.4K	$1.105M	$917.3K	$610.0K	$160.0K	$30.00K	$30.00K	$20.00K	$110.0K	$10.00K	$80.00K	$340.0K	$290.0K	$240.0K	$10.00K
YoY Change	-44.92%	20.42%	50.38%	281.25%	433.33%	0.0%	50.0%	-81.82%	1000.0%	-87.5%	-76.47%	17.24%	20.83%	2300.0%
Inventory	$4.718M	$3.549M	$2.048M	$1.150M	$750.0K	$0.00	$710.0K	$350.0K	$410.0K	$400.0K	$310.0K	$450.0K	$270.0K	$290.0K	$130.0K	$100.0K	$260.0K
Prepaid Expenses
Receivables	$8.533M	$7.004M	$2.990M	$2.270M	$1.340M	$210.0K	$840.0K	$790.0K	$450.0K	$280.0K	$220.0K	$200.0K	$60.00K	$450.0K	$30.00K	$30.00K	$30.00K
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$960.0K	$10.00K	$270.0K	$0.00	$80.00K
Total Short-Term Assets	$19.01M	$20.62M	$24.61M	$4.480M	$8.860M	$980.0K	$2.040M	$2.000M	$1.160M	$1.210M	$650.0K	$1.040M	$1.590M	$1.050M	$440.0K	$130.0K	$370.0K
YoY Change	-7.81%	-16.22%	449.3%	-49.44%	804.08%	-51.96%	2.0%	72.41%	-4.13%	86.15%	-37.5%	-34.59%	51.43%	138.64%	238.46%	-64.86%
Property, Plant & Equipment	$3.253M	$2.223M	$2.043M	$1.150M	$790.0K	$50.00K	$60.00K	$30.00K	$40.00K	$50.00K	$30.00K	$0.00	$0.00	$0.00	$0.00	$10.00K	$20.00K
YoY Change	46.35%	8.82%	77.62%	45.57%	1480.0%	-16.67%	100.0%	-25.0%	-20.0%	66.67%					-100.0%	-50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.084M	$3.084M	$5.017M	$1.100M		$1.960M
YoY Change	0.0%	-38.53%	356.12%
Other Assets											$0.00	$10.00K	$60.00K	$130.0K	$30.00K	$10.00K	$10.00K
YoY Change											-100.0%	-83.33%	-53.85%	333.33%	200.0%	0.0%
Total Long-Term Assets	$54.87M	$40.42M	$11.79M	$5.350M	$2.260M	$2.060M	$180.0K	$170.0K	$230.0K	$290.0K	$330.0K	$350.0K	$2.240M	$5.730M	$4.620M	$20.00K	$40.00K
YoY Change	35.74%	242.88%	120.34%	136.73%	9.71%	1044.44%	5.88%	-26.09%	-20.69%	-12.12%	-5.71%	-84.38%	-60.91%	24.03%	23000.0%	-50.0%
Total Assets	$73.87M	$61.04M	$36.40M	$9.830M	$11.12M	$3.040M	$2.220M	$2.170M	$1.390M	$1.500M	$980.0K	$1.390M	$3.830M	$6.780M	$5.060M	$150.0K	$410.0K
YoY Change
Accounts Payable	$2.002M	$1.427M	$594.0K	$490.0K	$410.0K	$120.0K	$290.0K	$330.0K	$240.0K	$210.0K	$190.0K	$210.0K	$0.00	$320.0K	$260.0K	$90.00K	$110.0K
YoY Change	40.31%	140.2%	21.22%	19.51%	241.67%	-58.62%	-12.12%	37.5%	14.29%	10.53%	-9.52%		-100.0%	23.08%	188.89%	-18.18%
Accrued Expenses	$10.09M	$10.22M	$5.428M	$3.050M	$2.230M	$280.0K	$620.0K	$640.0K	$600.0K	$510.0K	$510.0K	$1.230M	$900.0K	$1.010M	$510.0K	$370.0K	$280.0K
YoY Change	-1.28%	88.21%	77.98%	36.77%	696.43%	-54.84%	-3.13%	6.67%	17.65%	0.0%	-58.54%	36.67%	-10.89%	98.04%	37.84%	32.14%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.200M	$410.0K	$610.0K	$1.590M	$1.700M	$2.230M	$560.0K	$2.150M	$1.640M	$0.00	$1.510M
YoY Change						-100.0%	192.68%	-32.79%	-61.64%	-6.47%	-23.77%	298.21%	-73.95%	31.1%		-100.0%
Long-Term Debt Due	$580.4K						$0.00	$0.00	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$13.77M	$12.81M	$6.022M	$3.540M	$2.640M	$400.0K	$2.120M	$1.390M	$1.460M	$2.320M	$3.450M	$5.010M	$6.880M	$5.790M	$2.410M	$470.0K	$2.220M
YoY Change	7.51%	112.65%	70.12%	34.09%	560.0%	-81.13%	52.52%	-4.79%	-37.07%	-32.75%	-31.14%	-27.18%	18.83%	140.25%	412.77%	-78.83%
Long-Term Debt	$9.113M	$0.00	$0.00	$0.00	$1.500M	$1.500M	$0.00	$1.200M	$1.200M	$10.00K	$0.00	$190.0K	$810.0K	$440.0K	$0.00	$0.00	$0.00
YoY Change				-100.0%	0.0%		-100.0%	0.0%	11900.0%		-100.0%	-76.54%	84.09%
Other Long-Term Liabilities	$6.402M	$6.509M	$222.2K	$450.0K	$580.0K	$30.00K
YoY Change	-1.64%	2830.05%	-50.63%	-22.41%	1833.33%
Total Long-Term Liabilities	$15.52M	$6.509M	$222.2K	$450.0K	$2.080M	$1.530M	$0.00	$1.200M	$1.200M	$10.00K	$0.00	$190.0K	$810.0K	$440.0K	$0.00	$0.00	$0.00
YoY Change	138.36%	2830.05%	-50.63%	-78.37%	35.95%		-100.0%	0.0%	11900.0%		-100.0%	-76.54%	84.09%
Total Liabilities	$29.04M	$19.21M	$5.756M	$3.680M	$4.500M	$1.930M	$2.120M	$2.590M	$2.660M	$2.320M	$3.450M	$5.200M	$7.690M	$6.230M	$2.410M	$470.0K	$2.220M
YoY Change	51.18%	233.7%	56.41%	-18.22%	133.16%	-8.96%	-18.15%	-2.63%	14.66%	-32.75%	-33.65%	-32.38%	23.43%	158.51%	412.77%	-78.83%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	8.279M shares	7.907M shares	7.342M shares
Diluted Shares Outstanding	8.279M shares	7.907M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $314.16 Million

About Sanara MedTech Inc.

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. The company is headquartered in Fort Worth, Texas and currently employs 107 full-time employees. The company markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: Bioventus Inc. RxSight, Inc. United Health Products, Inc. ORASURE TECHNOLOGIES INC RETRACTABLE TECHNOLOGIES INC VOLITIONRX LTD SmileDirectClub, Inc. TELA Bio, Inc. UTAH MEDICAL PRODUCTS INC